Maria Betty Grace Bontigao-Emocling: 7 Years of Purpose-Driven Leadership at Boehringer Ingelheim
Maria Betty Grace Bontigao-Emocling, Therapeutic Area Lead – Cardiovascular and Lytics Business at Boehringer Ingelheim, shared a post on LinkedIn:
”Celebrating 7 years at Boehringer Ingelheim today-and feeling incredibly proud of the journey.
Over the years, I’ve been entrusted to lead and contribute across cardiovascular, respiratory, specialty care, rare disease, and now thrombosis care.
Each therapeutic area brought new challenges, deeper responsibility, and the opportunity to grow as a leader.
I’m grateful for leaders who believed in me, mentors who challenged me, and teammates who consistently show what excellence and collaboration look like. It’s an honor to help shape patient journeys and work alongside passionate key opinion leaders who share the same purpose.
Most proud to be leading a dynamic, resilient, and high‑performing One Stroke Care Team-a group driven by impact, teamwork, and commitment to patients.
Looking forward to more milestones, growth, and meaningful impact in the years ahead.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering